banner
DGAT inhibitor, AZD3988, Purity ≥98%
Inquiry

Cat. No.: X24-09-YM500

DGAT inhibitor, AZD3988, Purity ≥98%

Synonym: 892489-52-0; AZD 3988; AZD-3988; 2-[4-[4-[[5-(3,4-Difluoroanilino)-1,3,4-oxadiazole-2-carbonyl]amino]phenyl]cyclohexyl]acetic acid; DGAT inhibitor

  • CAS Number: 892489-52-0
  • Compound CID: 23648867
img
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
AZD3988 is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting DGAT. The molecular weight of the compound is 456.44, and its molecular formula is C23H22F2N4O4.
Molecular Weight
456.44
Molecular Formula
C23H22F2N4O4
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Confirmed by NMR/HPLC/MS.
Applications
AZD3988 can be studied extensively for its potential therapeutic applications in the treatment of inflammatory diseases and cancer due to its role in modulating immune responses and cell proliferation.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0